Energy-based Therapeutics Market Size, Share and Growth Outlook, 2026

Energy-based Therapeutics Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Energy-based Therapeutics Market size is forecast to increase from $8.84 Billion in 2026 to $13.36 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

The Energy-based Therapeutics market report provides detailed analysis and outlook of Energy-based Therapeutics segments including By Technology (Radiofrequency, Ultrasound, Cryotherapy, Microwave, Thermal, Hydro-mechanical, Electrical Stimulation, Laser, Magnetic Field Therapy), By Clinical Application (Aesthetics, Oncology, Cardiology, Orthopedics, Ophthalmology, Pain Management, Physiotherapy), By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Home-care Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Energy-Based Therapeutics Industry Overview

Tumor Treating Fields (TTFields) Expanding Non-Invasive Cancer Therapeutics

The energy-based therapeutics industry is advancing through the adoption of non-invasive biophysical treatment modalities designed to complement standard oncology care. Novocure received U.S. FDA premarket approval (PMA) for its Optune Pax device for adults with locally advanced, unresectable pancreatic cancer. The portable system is used alongside gemcitabine and paclitaxel chemotherapy regimens and applies alternating electric fields (Tumor Treating Fields, TTFields) at 150 kHz through torso patch arrays. This mechanism disrupts mitotic processes in cancer cells, reducing tumor proliferation while delaying pain progression. TTFields-based therapeutics represent a shift toward wearable, outpatient-compatible oncology devices that integrate seamlessly with systemic drug therapies. The ability to deliver targeted electric field therapy without adding systemic toxicity is reshaping non-invasive cancer treatment paradigms and expanding the role of device-based oncology interventions.

Clinical Survival Benefit Validation Strengthening Adoption of Electrical Field Therapy

Clinical validation is reinforcing the role of energy-based therapeutic systems in oncology through large-scale randomized trials demonstrating survival benefits. Novocure published efficacy data from its Phase III PANOVA-3 trial in the Journal of Clinical Oncology, involving 571 patients with locally advanced pancreatic cancer. The study demonstrated a statistically significant improvement in median overall survival to 16.2 months in the TTFields plus chemotherapy group compared to 14.2 months in the chemotherapy-only cohort, without additional systemic toxicities. These findings support broader clinical confidence in electrical field-based cancer therapies and highlight their compatibility with established chemotherapy regimens. The evidence base strengthens institutional adoption of wearable oncology devices and accelerates integration into standard treatment pathways for difficult-to-treat solid tumors.

Intravascular Lithotripsy Advancing Calcified Cardiovascular Disease Treatment

The energy-based therapeutics industry is also experiencing significant growth in interventional cardiology through acoustic energy-based plaque modification technologies. Shockwave Medical, Inc. expanded institutional adoption of its Intravascular Lithotripsy (IVL) platforms across cardiology departments for the treatment of calcified coronary arteries. The system delivers controlled acoustic pressure waves via balloon catheters to fracture hardened calcium deposits within stenosed vessels prior to stent implantation. This approach enables safer lesion preparation compared to traditional high-pressure balloon dilation or rotational atherectomy, reducing vessel trauma and procedural complexity. IVL systems are increasingly used in complex percutaneous coronary interventions where heavy calcification limits conventional treatment efficacy. The integration of acoustic energy therapy into catheter-based cardiovascular procedures is strengthening minimally invasive treatment options for high-risk cardiac patients.

Energy-based Therapeutics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Energy-based Therapeutics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Abbott Laboratories, Smith & Nephew plc, Olympus Corporation, B. Braun Melsungen AG, AngioDynamics, Inc., Stryker Corporation, Lumenis Ltd.. The Energy-based Therapeutics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Energy-based Therapeutics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Energy-based Therapeutics Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Energy-based Therapeutics companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Energy-based Therapeutics markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Energy-based Therapeutics Market Competitive Benchmarking and Company Analysis

Leading companies in Energy-based Therapeutics industry include- Medtronic plc, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Abbott Laboratories, Smith & Nephew plc, Olympus Corporation, B. Braun Melsungen AG, AngioDynamics, Inc., Stryker Corporation, Lumenis Ltd.. The Energy-based Therapeutics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Energy-based Therapeutics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Energy-based Therapeutics market remains one of the strongest-performing segments in the country.
The US Energy-based Therapeutics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Energy-based Therapeutics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Energy-based Therapeutics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Energy-based Therapeutics markets

Canada's strong Energy-based Therapeutics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Energy-based Therapeutics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Energy-based Therapeutics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Energy-based Therapeutics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Energy-based Therapeutics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Energy-based Therapeutics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Energy-based Therapeutics market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Energy-based Therapeutics sales through 2034

France Energy-based Therapeutics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Energy-based Therapeutics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Energy-based Therapeutics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Energy-based Therapeutics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Energy-based Therapeutics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Energy-based Therapeutics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Energy-based Therapeutics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Energy-based Therapeutics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Energy-based Therapeutics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Energy-based Therapeutics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Energy-based Therapeutics Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Energy-based Therapeutics Market Segmentation

By Technology
Radiofrequency
Ultrasound
Cryotherapy
Microwave
Thermal
Hydro-mechanical
Electrical Stimulation
Laser
Magnetic Field Therapy
By Clinical Application
Aesthetics
Oncology
Cardiology
Orthopedics
Ophthalmology
Pain Management
Physiotherapy
By End User
Hospitals
Specialty Clinics
Rehabilitation Centers
Home-care Settings

Top Companies in Energy-based Therapeutics Industry

Medtronic plc
Johnson & Johnson Services, Inc.
Boston Scientific Corporation
Abbott Laboratories
Smith & Nephew plc
Olympus Corporation
B. Braun Melsungen AG
AngioDynamics, Inc.
Stryker Corporation
Lumenis Ltd.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025